Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [619]

Updates in the ABC5 guidelines for the treatment of luminal metastatic breast...

Prof Nagi El Saghir - American University of Beirut Medical Center, Beirut...

Updates in the ABC5 guidelines for the treatment of luminal metastatic breast cancer ( Prof Nagi El Saghir - American University of Beirut Medical Center, Beirut, Lebanon )

Current controversies in breast cancer treatment

Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland

Current controversies in breast cancer treatment ( Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland )

Highlights from BGICC 2020

Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Highlights from BGICC 2020 ( Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Combining chemotherapy and hormone therapy for the treatment of luminal...

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Combining chemotherapy and hormone therapy for the treatment of luminal metastatic breast cancer ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Endocrine toxicities of immunotherapy

Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales

Endocrine toxicities of immunotherapy ( Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales )

Endocrine dysfunction in patients receiving immunotherapy

Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK

Endocrine dysfunction in patients receiving immunotherapy ( Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK )

The PEARL study: Palbociclib and endocrine therapy vs capecitabine in HR /HER2...

Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain

The PEARL study: Palbociclib and endocrine therapy vs capecitabine in HR /HER2- metastatic breast cancer ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )

Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women...

Dr Terry Mamounas - Orlando Health UF Health Cancer Center, Orlando, USA

Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone receptor-positive breast cancer ( Dr Terry Mamounas - Orlando Health UF Health Cancer Center, Orlando, USA )

Long-term influence of oestrogen plus progestin vs oestrogen alone on breast...

Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA

Long-term influence of oestrogen plus progestin vs oestrogen alone on breast cancer incidence in post-menopausal women ( Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA )

Breast cancer prevention in high-risk post-menopausal women

Prof Jack Cuzick - Queen Mary University of London, London, UK

Breast cancer prevention in high-risk post-menopausal women ( Prof Jack Cuzick - Queen Mary University of London, London, UK )

Preventative effects of anastrozole in post-menopausal women who are at high...

Prof Jack Cuzick - Queen Mary University of London, London, UK

Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer ( Prof Jack Cuzick - Queen Mary University of London, London, UK )

Breast cancer incidence in post-menopausal women: Long-term influence of...

Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA

Breast cancer incidence in post-menopausal women: Long-term influence of oestrogen plus progestin versus oestrogen alone ( Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA )

More from ecancer